Francesco Passamonti

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 39

Top Venues

Blood

Leukemia & lymphoma

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Leukemia

University of Insubria

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Insubria Nov 1o 2010

Italy

Director, Hematology :: Medicine

Publications

Francesco Passamonti, Youbei Lou, Manoj Chevli, Pranav Abraham
Real-world outcomes with fedratinib therapy in patients who discontinued ruxolitinib for primary myelofibrosis. Future oncology (London, England) (2023)
Nicola Stefano Fracchiolla, Alessandra Iurlo, Cristina Papayannidis, Antonella Vitale, Sabina Chiaretti, Mario Annunziata, Fabio Giglio, Prassede Salutari, Fabio Forghieri, Davide Lazzarotto, Monia Lunghi, Annalisa Imovilli, Barbara Scappini, Massimiliano Bonifacio, Michelina Dargenio, Carmela Gurrieri, Elisabetta Todisco, Marzia Defina, Maria Ilaria Del Principe, Patrizia Zappasodi, Marco Cerrano, Lidia Santoro, Elena Tagliaferri, Enrico Barozzi, Pasquale De Roberto, Marta Canzi, Elisa Buzzatti, Chiara Sartor, Francesco Passamonti, Robin Foà, Antonio Curti
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study. Cancers 15 (18) (2023)
Elisabetta Sauta, Marie Robin, Matteo Bersanelli, Erica Travaglino, Manja Meggendorfer, Lin-Pierre Zhao, Juan Carlos Caballero Berrocal, Claudia Sala, Giulia Maggioni, Bernardi Massimo, Carmen Di Grazia, Luca Vago, Giulia Rivoli, Lorenza Borin, Saverio D'Amico, Cristina Astrid Tentori, Marta Ubezio, Alessia Campagna, Antonio Russo, Daniele Mannina, Luca Lanino, Patrizia Chiusolo, Luisa Giaccone, Maria Teresa Teresa Voso, Marta Riva, Esther Natalie Oliva, Matteo Zampini, Elena Riva, Olivier Nibourel, Maria Elena Bicchieri, Niccolo' Bolli, Alessandro Rambaldi, Francesco Passamonti, Victor Savevski, Armando Santoro, Ulrich Germing, Shahram Kordasti, Valeria Santini, Maria Diez-Campelo, Guillermo F Sanz, Francesc Sole, Wolfgang Kern, Uwe Platzbecker, Lionel Ades, Pierre Fenaux, Torsten Haferlach, Gastone C Castellani, Matteo Giovanni Della Porta
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
John O Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, Francesca Palandri, Timothy Devos, Francesco Passamonti, Raajit K Rampal, Adam J Mead, Gabriella Hobbs, Joseph M Scandura, Moshe Talpaz, Nikki Granacher, Tim C P Somervaille, Ronald Hoffman, Marielle J Wondergem, Mohamed E Salama, Gozde Colak, Jike Cui, Jean-Jacques Kiladjian, Alessandro Maria Maria Vannucchi, Srdan Verstovsek, Natalia Curto-García, Claire N Harrison, Vikas K Gupta
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Francesco Passamonti, Alessandra Bandera
Early treatment for COVID-19 in patients with haematological malignancies: Much more than a recommendation! British journal of haematology (2023)
Alessandra Carobbio, Alessandro Maria Vannucchi, Elisa Rumi, Valerio De Stefano, Alessandro Rambaldi, Giuseppe Carli, Maria Luigia Randi, Heinz Gisslinger, Francesco Passamonti, Juergen Thiele, Naseema Gangat, Ayalew Tefferi, Tiziano Barbui
Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach. Blood cancer journal 13 (1) (2023)
Shaimaa El-Ashwah, Jon Salmanton-García, Yavuz M Bilgin, Federico Itri, Pavel Žák, Barbora Weinbergerová, Luisa Verga, Ali S Omrani, Maria Gomes da Silva, Tomáš Szotkowski, Monia Marchetti, Caterina Buquicchio, Marcio Nucci, Martin Schönlein, Francesca Farina, Caroline Besson, Lucia Prezioso, Summiya Nizamuddin, Julio Dávila-Valls, Sonia Martin-Perez, Valentina Bonuomo, Jaap A van Doesum, Maria Chiara Tisi, Francesco Passamonti, Gustavo-Adolfo Mendez, Stef Meers, Johan A Maertens, Alberto López-García, Andreas Glenthoej, Matteo Bonnani, Ikhwan Rinaldi, Irati Ormazabal-Vélez, Jorge Labrador, Austin G Kulasekararaj, Ildefonso Espigado, Fatih Demirkan, Nick Alexander De Jonge, Graham P Collins, Maria Calbacho, Ola Blennow, Murtadha K Al-Khabori, Tatjana Adžić-Vukičević, Elena Arellano, Bojana Mišković, Miloš Mladenovic, Anna Nordlander, Zdenek Rácil, Emanuele Ammatuna, Raul Cordoba, Ditte Stampe Hersby, Stefanie K Grafe, Ziad Emarah, Michaela Hanakova, Maria Vittoria Sacchi, Marriyam Ijaz, Laman Rahimli, Raquel Nunes-Rodrigues, Giovanni Paolo Maria Zambrotta, Francesco Marchesi, Oliver Andreas Cornely, Livio Pagano
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey. Leukemia & lymphoma (2023)
Barbara Mora, Margherita Maffioli, Elisa Rumi, Paola Guglielmelli, Marianna Caramella, Andrew T Kuykendall, Francesca Palandri, Alessandra Iurlo, Valerio De Stefano, Jean-Jacques Kiladjian, Elena M Elli, Nicola Polverelli, Jason Gotlib, Francesco Albano, Richard T Silver, Giulia Benevolo, David M Ross, Timothy Devos, Oscar Borsani, Tiziano Barbui, Matteo G Della Porta, Lorenza Bertù, Rami S Komrokji, Alessandro M Vannucchi, Francesco Passamonti
Incidence of blast phase in myelofibrosis according to anemia severity. EJHaem 4 (3) (2023)
Michele Merli, Francesco Passamonti, Luca Arcaini
Deciphering molecular complexity of HCV-associated lymphoproliferation. British journal of haematology (2023)
Daniel A Arber, Attilio Orazi, Robert P Hasserjian, Michael J Borowitz, Katherine R Calvo, Hans Michael Kvasnicka, Sa A Wang, Adam Bagg, Tiziano Barbui, Susan Branford, Carlos E Bueso-Ramos, Jorge E Cortes, Paola Dal Cin, Courtney D Di Nardo, Hervé Dombret, Eric J Duncavage, Benjamin L Ebert, Elihu H Estey, Fabio Facchetti, Kathryn Foucar, Naseema Gangat, Umberto Gianelli, Lucy A Godley, Nicola Gökbuget, Jason Gotlib, Eva Hellström-Lindberg, Gabriela S Hobbs, Ronald Hoffman, Elias J Jabbour, Jean-Jacques Kiladjian, Richard A Larson, Michelle M Le Beau, Mignon L-C Loh, Bob Löwenberg, Elizabeth A Macintyre, Luca Malcovati, Charles G Mullighan, Charlotte M Niemeyer, Olatoyosi M Odenike, Seishi Ogawa, Alberto Orfao, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching-Hon Pui, Jerald P Radich, Andreas Reiter, Maria Rozman, Martina Rudelius, Michael R Savona, Charles A Schiffer, Annette Schmitt-Graeff, Akiko Shimamura, Jorge Sierra, Wendy A Stock, Richard M Stone, Martin S Tallman, Jürgen Thiele, Hwei-Fang Tien, Alexandar Tzankov, Alessandro Maria Maria Vannucchi, Paresh Vyas, Andrew H Wei, Olga K Weinberg, Agnieszka Świątek, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140 (11) (2022)
Michele Merli, Sara Rattotti, Michele Spina, Francesca Re, Marina Motta, Francesco A Piazza, Lorella Orsucci, Andrés José Maria Ferreri, Omar Perbellini, Anna Dodero, Daniele Vallisa, Alessandro Pulsoni, Armando Santoro, Paolo Sacchi, Valentina Zuccaro, Emanuela Chimienti, Filomena Russo, Chiara Rusconi, Anna Linda Zignego, Luigi Marcheselli, Francesco Passamonti, Stefano Luminari, Marco Paulli, Raffaele Bruno, Luca Arcaini, null null
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (35) (2022)
Francesco Passamonti, Emanuele Nicastri, Alice Di Rocco, Attilio Guarini, Adalberto Ibatici, Stefano Luminari, Malgorzata Mikulska, Carlo Visco
Management of patients with lymphoma and COVID-19: Narrative review and evidence-based practical recommendations. Hematological oncology (2022)
Tiziano Barbui, Arianna Ghirardi, Alessandra Carobbio, Arianna Masciulli, Greta Carioli, Alessandro Rambaldi, Maria Chiara Finazzi, Marta Bellini, Elisa Rumi, Daniele Vanni, Oscar Borsani, Francesco Passamonti, Barbara Mora, Marco Brociner, Paola Guglielmelli, Chiara Paoli, Alberto Alvarez-Larran, Ana Triguero, Marta Garrote, Helna Pettersson, Björn Andréasson, Giovanni Barosi, Alessandro Maria Maria Vannucchi
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score. Blood cancer journal 12 (11) (2022)
Michele Merli, Isacco Ferrarini, Francesco Merli, Alessandro Busca, Roberto Mina, Brunangelo Falini, Riccardo Bruna, Roberto Cairoli, Monia Marchetti, Alessandra Romano, Michele Cavo, Luca Arcaini, Francesco Angotzi, Chiara Cattaneo, Enrico Derenzini, Nicola Stefano Fracchiolla, Francesco Marchesi, Annamaria Scattolin, Atto Billio, Monica Bocchia, Massimo Massaia, Carlo Gambacorti-Passerini, Francesca Romana Mauro, Massimo Gentile, Sara Mohamed, Matteo Giovanni Della Porta, Elisa Coviello, Daniela Cilloni, Giuseppe Visani, Augusto Bramante Federici, Maria Chiara Tisi, Laura Cudillo, Sara Galimberti, Filippo Gherlinzoni, Livio Pagano, Anna Guidetti, Lorenza Bertù, Paolo Corradini, Francesco Passamonti, Carlo Visco
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort. Hematological oncology (2022)
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Ola Blennow, Maria Gomes da Silva, Andreas Glenthøj, Jaap A van Doesum, Yavuz M Bilgin, Alberto López-García, Federico Itri, Raquel Nunes Rodrigues, Barbora Weinbergerová, Francesca Farina, Giulia Dragonetti, Caroline Berg Venemyr, Jens Tomas Van Praet, Ozren Jaksic, Toni Valkovic, Iker Falces-Romero, Sonia Martin-Perez, Moraima Jiménez, Julio Dávila-Valls, Martin Schönlein, Emanuele Ammatuna, Stef Meers, Mario Delia, Zlate Stojanoski, Anna Nordlander, Tobias Lahmer, László Imre Pinczés, Caterina Buquicchio, Klára Piukovics, Irati Ormazabal-Velez, Nicola Stefano Fracchiolla, Michalis Samarkos, Gustavo-Adolfo Mendez, Jose-Ángel Hernández-Rivas, Ildefonso Espigado, Martin Cernan, Verena Petzer, Sylvain Lamure, Roberta Di Blasi, Joyce Marques de Almeida, Michelina Dargenio, Monika Maria Biernat, Mariarita Sciumè, Cristina de Ramón, Nick Alexander De Jonge, Josip Batinic, Avinash Aujayeb, Monia Marchetti, Guillemette Fouquet, Noemi Fernández Escalada, Giovanni Paolo Maria Zambrotta, Maria Vittoria Sacchi, Anna Guidetti, Fatih Demirken, Lucia Prezioso, Zdenek Racil, Marcio Nucci, Miloš Mladenovic, Raphael Lievin, Michaela Hanakova, Stefanie K Grafe, Uluhan Sili, Marina Machado, Chiara Cattaneo, Tatjana Adzic-Vukicevic, Luisa Verga, Jorge Labrador, Laman Rahimli, Matteo Bonanni, Francesco Passamonti, Antonio Pagliuca, Paolo Corradini, Martin Hoenigl, Philipp Koehler, Alessandro Busca, Oliver Andreas Cornely
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from EPICOVIDEHA survey. Blood (2022)
Francesco Passamonti, Barbara Mora
Myelofibrosis. Blood (2022)
Margherita Maffioli, Barbara Mora, Somedeb Ball, Alessandra Iurlo, Elena Maria Elli, Maria Chiara Finazzi, Nicola Polverelli, Elisa Rumi, Marianna Caramella, Maria Cristina Carraro, Mariella D'Adda, Alfredo Molteni, Cinzia Sissa, Francesca Lunghi, Alessandro Vismara, Marta Ubezio, Anna Guidetti, Sabrina Caberlon, Michela Anghilieri, Rami S Komrokji, Daniele Cattaneo, Matteo Giovanni Della Porta, Toni Giorgino, Lorenza Bertù, Marco Brociner, Andrew T Kuykendall, Francesco Passamonti
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis. Blood advances 6 (6) (2022)
John O Mascarenhas, Francesco Passamonti, Kate Burbury, Tarec Christoffer El-Galaly, Aaron T Gerds, Vikas K Gupta, Brian Higgins, Kathrin Wonde, Candice Jamois, Bruno Kovic, Ling-Yuh Huw, Sudhakar Katakam, Margherita Maffioli, Ruben A Mesa, Jeanne Palmer, Marta Bellini, David Morrall Ross, Alessandro Maria Maria Vannucchi, Abdulraheem Yacoub
The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study. Blood advances 6 (4) (2022)
Barbara Mora, Paola Guglielmelli, Andrew Kuykendall, Elisa Rumi, Margherita Maffioli, Francesca Palandri, Valerio De Stefano, Marianna Caramella, Silvia Salmoiraghi, Jean-Jacques Kiladjian, Jason Gotlib, Alessandra Iurlo, Francisco Cervantes, Marco Ruggeri, Richard T Silver, Francesco Albano, Giulia Benevolo, David Morrall Ross, Matteo G Della Porta, Timothy Devos, Giada Rotunno, Rami S Komrokji, Ilaria C Casetti, Michele Merli, Marco Brociner, Domenica Caramazza, Giuseppe Auteri, Tiziano Barbui, Daniele Cattaneo, Lorenza Bertù, Luca Arcaini, Alessandro M Vannucchi, Francesco Passamonti
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients. Leukemia 36 (10) (2022)
Sylvain Lamure, Jon Salmanton-García, Elena Robin-Marieton, Ozren Jaksic, Milena Kohn, Francesco Marchesi, Monia Marchetti, Shaimaa El-Ashwah, Fatih Demirkan, Toni Valković, Noemí Fernández, Maria Chiara Tisi, Zlate Stojanoski, Guldane Cengiz Seval, Osman Ilhan, Lucia Prezioso, Maria Merelli, Alberto López-García, Marie-Pierre Ledoux, Austin G Kulasekararaj, Tomás-José González-López, Maria Gomes da Silva, Ziad Emarah, Rafael F Duarte, Chiara Cattaneo, Ola Blennow, Yavuz M Bilgin, Rui Bergantim, Josip Batinić, Raul Cordoba, Jenna Essame, Anna Nordlander, Raquel Nunes-Rodrigues, Maria Vittoria Sacchi, Sofia Zompi, Alessandro Busca, Paolo Corradini, Martin Hoenigl, Nikolai N Klimko, Philipp Köhler, Antonio Pagliuca, Francesco Passamonti, Rémy Duléry, Oliver Andreas Cornely, Caroline Besson, Livio Pagano
COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey. Blood advances 6 (13) (2022)
Francisco Cervantes, David M Ross, Atanas Radinoff, Francesca Palandri, Alexandr Myasnikov, Alessandro M Vannucchi, Pierre Zachee, Heinz Gisslinger, Norio Komatsu, Lynda Foltz, Francesco Mannelli, Francesco Passamonti, Geralyn Gilotti, Islam Sadek, Ranjan Tiwari, Evren Zor, Haifa Kathrin Al-Ali
Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study. Leukemia 35 (12) (2021)
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Alberto López-García, Sylvain Lamure, Federico Itri, Maria Gomes da Silva, Giulia Dragonetti, Iker Falces-Romero, Jaap A van Doesum, Uluhan Sili, Jorge Labrador, Maria Calbacho, Yavuz Bilgin, Barbora Weinbergerová, Laura Milena Serrano Gomez, Josep-María Ribera, Sandra Malak, Jose Loureiro Amigo, Andreas Glenthoej, Raul Cordoba, Raquel Nunes Rodrigues, Tomas Jose Gonzalez-Lopez, Linda Katharina Karlsson, Maria-Jose Jimenez, Jose-Ángel Hernández-Rivas, Ozren Jaksic, Zdenek Racil, Alessandro Busca, Paolo Corradini, Martin Hoenigl, Nikolai N Klimko, Philipp Koehler, Antonio Pagliuca, Francesco Passamonti, Oliver Andreas Cornely
COVID-19 in vaccinated adult patients with hematological malignancies. Preliminary results from EPICOVIDEHA. Blood (2021)
Francesco Passamonti, Alessandra Romano, Marco Salvini, Francesco Merli, Matteo G Della Porta, Riccardo Bruna, Elisa Coviello, Ilaria Romano, Roberto Cairoli, Roberto Lemoli, Francesca Farina, Adriano Venditti, Alessandro Busca, Marco Ladetto, Massimo Massaia, Antonello Pinto, Luca Arcaini, Agostino Tafuri, Francesco Marchesi, Nicola Fracchiolla, Monica Bocchia, Daniele Armiento, Anna Candoni, Mauro Krampera, Mario Luppi, Valeria Cardinali, Sara Galimberti, Chiara Cattaneo, Elettra Ortu La Barbera, Roberto Mina, Francesco Lanza, Giuseppe Visani, Pellegrino Musto, Luigi Petrucci, Francesco Zaja, Paolo A Grossi, Lorenza Bertù, Livio Pagano, Paolo Corradini, null null
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. British journal of haematology 195 (3) (2021)
Paola Guglielmelli, Francesca Palandri, Carmine Selleri, Daniela Cilloni, Francesco Mendicino, Patrizio Mazza, Domenico Pastore, Giuseppe A Palumbo, Marco Santoro, Vincenzo Pavone, Stefana Impera, Mara Morelli, Paola Coco, Diletta Valsecchi, Francesco Passamonti, Massimo Breccia, null null
Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI). Leukemia & lymphoma (2021)
Francesco Passamonti, Vikas Gupta, Bruno Martino, Lynda Foltz, Andrey Zaritskey, Haifa Kathrin Al-Ali, Renato Tavares, Margherita Maffioli, Pia Raanani, Pilar Giraldo, Martin Griesshammer, Paola Guglielmelli, Catherine Bouard, Carole Paley, Ranjan Tiwari, Alessandro M Vannucchi
Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low-, intermediate-1-, intermediate-2-, and high-risk myelofibrosis in JUMP, a Phase 3b, expanded-access study. Hematological oncology 39 (4) (2021)
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Alessandro Busca, Paolo Corradini, Martin Hoenigl, Nikolai N Klimko, Philipp Köhler, Antonio Pagliuca, Francesco Passamonti, Luisa Verga, Benjamin Víšek, Osman Ilhan, Gianpaolo Nadali, Barbora Weinbergerová, Raul Cordoba, Monia Marchetti, Graham P Collins, Francesca Farina, Chiara Cattaneo, Alba Cabirta, Maria Gomes da Silva, Federico Itri, Jaap A van Doesum, Marie-Pierre Ledoux, Martin Čerňan, Ozren Jaksic, Rafael F Duarte, Gabriele Magliano, Ali S Omrani, Nicola Stefano Fracchiolla, Austin G Kulasekararaj, Toni Valković, Christian Bjørn Poulsen, Marina Machado, Andreas Glenthoej, Igor Stoma, Zdenek Rácil, Klára Piukovics, Milan Navrátil, Ziad Emarah, Uluhan Sili, Johan A Maertens, Ola Blennow, Rui Bergantim, Carolina García-Vidal, Lucia Prezioso, Anna Guidetti, Maria Ilaria Del Principe, Marina Olegovna Popova, Nick Alexander De Jonge, Irati Ormazabal-Vélez, Noemí Fernández, Iker Falces-Romero, Annarosa Cuccaro, Stef Meers, Caterina Buquicchio, Darko Antic, Murtadha K Al-Khabori, Miriam Santero, Monika Maria Biernat, Maria Chiara Tisi, Ertan Sal, Laman Rahimli, Natasa Čolović, Martin Schönlein, Maria Calbacho, Carlo Tascini, Carolina Miranda-Castillo, Nina Khanna, Gustavo-Adolfo Mendez, Verena Petzer, Jan Novák, Caroline Besson, Rémy Duléry, Sylvain Lamure, Marcio Nucci, Giovanni Paolo Maria Zambrotta, Pavel Žák, Guldane Cengiz Seval, Valentina Bonuomo, Jiří Mayer, Alberto López-García, Maria Vittoria Sacchi, Stephen W Booth, Fabio Ciceri, Margherita Oberti, Marco Salvini, Macarena Izuzquiza, Raquel Nunes-Rodrigues, Emanuele Ammatuna, Aleš Obr, Raoul Herbrecht, Lucía Núñez-Martín-Buitrago, Valentina Mancini, Hawraa Shwaylia, Alessandra Iurlo, Jenna Essame, Marietta Nygaard, Josip Batinić, Yung Gonzaga, Isabel Regalado-Artamendi, Linda Katharina Karlsson, Maryia Shapetska, Michaela Hanakova, Shaimaa El-Ashwah, Zita Borbényi, Gökçe Melis Çolak, Anna Nordlander, Matteo Bonnani, Alessio Maria Edoardo Maraglino, Amelia Rinaldi, Cristina De Ramón-Sánchez, Oliver Andreas Cornely, null null
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). Journal of hematology & oncology 14 (1) (2021)
Marianna Rossi, Manja Meggendorfer, Matteo Zampini, Mauro Tettamanti, Emma Riva, Erica Travaglino, Matteo Bersanelli, Sara Mandelli, Alessia Antonella Galbussera, Ettore Mosca, Elena Saba, Chiara Chiereghin, Nicla Manes, Chiara Milanesi, Marta Ubezio, Lucio Morabito, Clelia Peano, Giulia Soldà, Rosanna Asselta, Stefano Duga, Carlo Francesco Selmi, Maria De Santis, Karolina Malik, Giulia Maggioni, Maria Elena Bicchieri, Alessia Campagna, Cristina A Tentori, Antonio Russo, Efrem Civilini, Paola Allavena, Rocco Giovanni Piazza, Giovanni Corrao, Claudia Sala, Alberto Termanini, Laura Giordano, Paolo Detoma, Aurelio Malabaila, Luca Sala, Stefano Rosso, Roberto Zanetti, Claudia Saitta, Elena Riva, Gianluigi Condorelli, Francesco Passamonti, Armando Santoro, Francesc Sole, Uwe Platzbecker, Pierre Fenaux, Niccolò Bolli, Gastone Castellani, Wolfgang Kern, George S Vassiliou, Torsten Haferlach, Ugo Lucca, Matteo Giovanni Della Porta
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years. Blood 138 (21) (2021)
Michele Merli, Francesco Passamonti, Luca Arcaini
The double significance of idelalisib immune-related toxicity. Leukemia & lymphoma 62 (12) (2021)
Matteo Bersanelli, Erica Travaglino, Manja Meggendorfer, Tommaso Matteuzzi, Claudia Sala, Ettore Mosca, Chiara Chiereghin, Noemi Di Nanni, Matteo Gnocchi, Matteo Zampini, Marianna Rossi, Giulia Maggioni, Alberto Termanini, Emanuele Angelucci, Bernardi Massimo, Lorenza Borin, Benedetto Bruno, Francesca Bonifazi, Valeria Santini, Andrea Bacigalupo, Maria Teresa Teresa Voso, Esther Natalie Oliva, Marta Riva, Marta Ubezio, Lucio Morabito, Alessia Campagna, Claudia Saitta, Victor Savevski, Enrico Giampieri, Daniel Remondini, Francesco Passamonti, Fabio Ciceri, Niccolò Bolli, Alessandro Rambaldi, Wolfgang Kern, Shahram Kordasti, Francesc Sole, Laura Palomo, Guillermo F Sanz, Armando Santoro, Uwe Platzbecker, Pierre Fenaux, Luciano Milanesi, Torsten Haferlach, Gastone C Castellani, Matteo Giovanni Della Porta
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (11) (2021)
Michele Merli, Irene Defrancesco, Carlo Visco, Caroline Besson, Alice Di Rocco, Annalisa Arcari, Antonello Sica, Emanuele Cencini, Maria Chiara Tisi, Marco Frigeni, Paolo Grossi, Benedetta Bianchi, Barbara Mora, Lorenza Bertù, Raffaele Bruno, Francesco Passamonti, Luca Arcaini
Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphoma. Leukemia & lymphoma 61 (9) (2020)
Claire N Harrison, Nicolaas Schaap, Alessandro M Vannucchi, Jean-Jacques Kiladjian, Eric Jourdan, Richard T Silver, Harry C Schouten, Francesco Passamonti, Sonja Zweegman, Moshe Talpaz, Srdan Verstovsek, Shelonitda Rose, Juan Shen, Tymara Berry, Carrie Brownstein, Ruben A Mesa
Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure. American journal of hematology 95 (6) (2020)
Barbara Mora, Claudia Siracusa, Elisa Rumi, Margherita Maffioli, Ilaria Carola Casetti, Daniela Barraco, Michele Merli, Marianna Rossi, Marta Ubezio, Raffaella Accetta, Laura Libera, Daniela Pietra, Chiara Trotti, Silvia Uccella, Francesco Pallotti, Rosario Casalone, Lorenza Bertù, Luca Arcaini, Matteo Giovanni Della Porta, Francesco Passamonti
Platelet count predicts driver mutations' co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis. Leukemia 35 (5) (2020)
Michele Merli, Dario Marino, Emanuele Cencini, Sara Rattotti, Costanza Fraenza, Paolo Grossi, Benedetta Bianchi, Barbara Mora, Roberta Sciarra, Silvia Finotto, Bianca Mecacci, Francesco Passamonti, Carlo Visco, Luca Arcaini
Direct-acting antivirals in hepatitis C virus-positive mantle cell lymphomas. Hematological oncology 39 (2) (2020)
Francesca Palandri, Alfonso Piciocchi, Valerio De Stefano, Massimo Breccia, Guido Finazzi, Alessandra Iurlo, Paola Fazi, Stefano Soddu, Bruno Martino, Sergio Siragusa, Francesco Albano, Francesco Passamonti, Marco Vignetti, Alessandro M Vannucchi
How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey. Leukemia 34 (10) (2020)
Giuseppe Gaetano Loscocco, Francesco Mannelli, Paola Guglielmelli, Chiara Paoli, Ilaria Marone, Rosalba Cucci, Giacomo Coltro, Benedetta Sordi, Francesco Albano, Massimo Breccia, Valerio De Stefano, Guido Finazzi, Alessandra Iurlo, Bruno Martino, Francesca Palandri, Francesco Passamonti, Sergio Siragusa, Lara Mannelli, Duccio Fantoni, Paola Fazi, Sergio Amadori, Marco Vignetti, Tiziano Barbui, Alessandro Maria Maria Vannucchi
Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative. American journal of hematology 94 (9) (2019)
Michele Merli, Francesco Passamonti
A final note about ibrutinib in relapsed or refractory CLL: Conclusive results from RESONATE sound definitely good! American journal of hematology 94 (12) (2019)
Francesco Passamonti
Stem cell transplant in MF: it's time to personalize. Blood 133 (20) (2019)
Barbara Mora, Elisa Rumi, Paola Guglielmelli, Daniela Barraco, Margherita Maffioli, Alessandro Rambaldi, Marianna Caramella, Rami S Komrokji, Jason Gotlib, Jean Jacques Kiladjian, Francisco Cervantes, Timothy Devos, Francesca Palandri, Valerio De Stefano, Marco Ruggeri, Richard T Silver, Giulia Benevolo, Francesco Albano, Chiara Cavalloni, Daniela Pietra, Tiziano Barbui, Giada Rotunno, Mario Cazzola, Alessandro Maria Vannucchi, Toni Giorgino, Francesco Passamonti
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients. Cancer medicine 8 (9) (2019)
Barbara Mora, Paola Guglielmelli, Elisa Rumi, Margherita Maffioli, Daniela Barraco, Alessandro Rambaldi, Marianna Caramella, Rami S Komrokji, Jean-Jacques Kiladjian, Jason Gotlib, Alessandra Iurlo, Francisco Cervantes, Timothy Devos, Francesca Palandri, Valerio De Stefano, Marco Ruggeri, Richard T Silver, Francesco Albano, Giulia Benevolo, Chiara Cavalloni, Silvia Uccella, Raffaella Accetta, Claudia Siracusa, Stefania Agnoli, Michele Merli, Tiziano Barbui, Lorenza Bertù, Mario Cazzola, Alessandro Maria Maria Vannucchi, Francesco Passamonti
Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group. American journal of hematology 95 (1) (2019)
Francesco Passamonti
PDGFRB disease: right diagnosis to prolong survival. Blood 123 (23) (2014)

Francesco Passamonti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Francesco Passamonti